MGRM — Monogram Orthopaedics Share Price
- $153.11m
- $139.52m
- $0.37m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 11.43 | ||
Price to Tang. Book | 11.92 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 419.48 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -125.49% | ||
Return on Equity | -156.75% | ||
Operating Margin | -4730.97% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | n/a | n/a | 0.63 | n/a | 0.36 | 1.11 | 5.7 | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Monogram Orthopaedics Inc. (Monogram) is engaged in developing a product solution architecture that enables patient-optimized orthopedic implants by linking three-dimensional (3D) printing and robotics with advanced pre-operative imaging. Its primary business is to market orthopedic implants insertable with its orthopedic robot. The Company has a robot prototype that can autonomously execute optimized paths for precision insertion of implants in simulated cadaveric surgeries. The Monogram robotic system and related hardware (end-effector) are multi-use capital equipment. The Monogram technology platform consists of a workflow to prepare a patient-specific surgical plan from a computed tomography (CT) scan. Monogram intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- April 21st, 2016
- Public Since
- May 18th, 2023
- No. of Employees
- 28
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 62,932,808
- Address
- 53 Bridge St Apt 507, BROOKLYN, 11201-7903
- Web
- https://www.monogramorthopedics.com
- Phone
- +1 7185763205
- Auditors
- Fruci & Associates II, PLLC
Similar to MGRM
Accelerate Diagnostics
NASDAQ Capital Market
Acutus Medical
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
FAQ
As of Today at 19:15 UTC, shares in Monogram Orthopaedics are trading at $2.43. This share price information is delayed by 15 minutes.
Shares in Monogram Orthopaedics last closed at $2.43 and the price had moved by over the past 365 days. In terms of relative price strength the Monogram Orthopaedics share price has matched the S&P500 Index by over the past year.
There is no consensus recommendation for this security.
Monogram Orthopaedics does not currently pay a dividend.
Monogram Orthopaedics does not currently pay a dividend.
Monogram Orthopaedics does not currently pay a dividend.
To buy shares in Monogram Orthopaedics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $2.43, shares in Monogram Orthopaedics had a market capitalisation of $153.11m.
Here are the trading details for Monogram Orthopaedics:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: MGRM
Based on an overall assessment of its quality, value and momentum Monogram Orthopaedics is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Monogram Orthopaedics is $6.00. That is 146.62% above the last closing price of $2.43.
Analysts covering Monogram Orthopaedics currently have a consensus Earnings Per Share (EPS) forecast of -$0.43 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Monogram Orthopaedics. Over the past six months, its share price has underperformed the S&P500 Index by -30.98%.
As of the last closing price of $2.43, shares in Monogram Orthopaedics were trading -25.88% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Monogram Orthopaedics PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.43.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Monogram Orthopaedics' directors